207 related articles for article (PubMed ID: 7530269)
1. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models.
Tsuboi R; Shi CM; Sato C; Cox GN; Ogawa H
J Invest Dermatol; 1995 Feb; 104(2):199-203. PubMed ID: 7530269
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-I and growth hormone in hypophysectomized rats.
Cox GN; McDermott MJ; Merkel E; Stroh CA; Ko SC; Squires CH; Gleason TM; Russell D
Endocrinology; 1994 Nov; 135(5):1913-20. PubMed ID: 7525258
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): effects on the glycemic and growth promoting activities of rhIGF-1 in the rat.
Clark RG; Mortensen D; Reifsynder D; Mohler M; Etcheverry T; Mukku V
Growth Regul; 1993 Mar; 3(1):50-2. PubMed ID: 7683530
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
Camacho-Hübner C; Rose S; Preece MA; Sleevi M; Storr HL; Miraki-Moud F; Minuto F; Frystyk J; Rogol A; Allan G; Sommer A; Savage MO
J Clin Endocrinol Metab; 2006 Apr; 91(4):1246-53. PubMed ID: 16403822
[TBL] [Abstract][Full Text] [Related]
5. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice.
Tsuboi R; Rifkin DB
J Exp Med; 1990 Jul; 172(1):245-51. PubMed ID: 2358777
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined recombinant insulin-like growth factor (IGF)-I and IGF binding protein-3 in type 2 diabetic patients on glycemic control and distribution of IGF-I and IGF-II among serum binding protein complexes.
Clemmons DR; Sleevi M; Allan G; Sommer A
J Clin Endocrinol Metab; 2007 Jul; 92(7):2652-8. PubMed ID: 17426090
[TBL] [Abstract][Full Text] [Related]
7. Mecasermin rinfabate: insulin-like growth factor-I/insulin-like growth factor binding protein-3, mecaserimin rinfibate, rhIGF-I/rhIGFBP-3.
Drugs R D; 2005; 6(2):120-7. PubMed ID: 15777106
[TBL] [Abstract][Full Text] [Related]
8. Insulin-Like Growth Factor 1 in the Preterm Rabbit Pup: Characterization of Cerebrovascular Maturation following Administration of Recombinant Human Insulin-Like Growth Factor 1/Insulin-Like Growth Factor 1-Binding Protein 3.
Gram M; Ekström C; Holmqvist B; Carey G; Wang X; Vallius S; Hellström W; Ortenlöf N; Agyemang AA; Smith LEH; Hellström A; Mangili A; Barton N; Ley D
Dev Neurosci; 2021; 43(5):281-295. PubMed ID: 34218224
[TBL] [Abstract][Full Text] [Related]
9. rhIGF-I/IGFBP-3 complex, but not free rhIGF-I, supports muscle protein biosynthesis in rats during semistarvation.
Svanberg E; Ohlsson C; Kimball SR; Lundholm K
Eur J Clin Invest; 2000 May; 30(5):438-46. PubMed ID: 10809904
[TBL] [Abstract][Full Text] [Related]
10. Safety aspects of longitudinal administration of IGF-I/IGFBP-3 complex in neonatal mice.
Hellgren G; Han W; Wang X; Löfqvist C; Hagberg H; Mallard C; Hellström A
Growth Horm IGF Res; 2011 Aug; 21(4):205-11. PubMed ID: 21696987
[TBL] [Abstract][Full Text] [Related]
11. Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study.
Hansen-Pupp I; Hellström A; Hamdani M; Tocoian A; Kreher NC; Ley D; Hallberg B
Growth Horm IGF Res; 2017 Oct; 36():44-51. PubMed ID: 28934640
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of IL-6 and IGFBP-1 predict low serum IGF-1 levels during continuous infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants.
Klevebro S; Hellgren G; Hansen-Pupp I; Wackernagel D; Hallberg B; Borg J; Pivodic A; Smith L; Ley D; Hellström A
Growth Horm IGF Res; 2020 Feb; 50():1-8. PubMed ID: 31756675
[TBL] [Abstract][Full Text] [Related]
14. The effects of recombinant human insulin-like growth factor-1/insulin-like growth factor binding protein-3 administration on lipid and carbohydrate metabolism in recreational athletes.
Guha N; Nevitt SP; Francis M; Böhning W; Böhning D; Sönksen PH; Holt RIG
Clin Endocrinol (Oxf); 2021 Apr; 94(4):551-562. PubMed ID: 33249593
[TBL] [Abstract][Full Text] [Related]
15. Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes.
Guha N; Erotokritou-Mulligan I; Nevitt SP; Francis M; Bartlett C; Cowan DA; Bassett EE; Sönksen PH; Holt RI
Drug Test Anal; 2013; 5(11-12):843-9. PubMed ID: 24173773
[TBL] [Abstract][Full Text] [Related]
16. Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats.
Bagi CM; DeLeon E; Brommage R; Adams S; Rosen D; Sommer A
Bone; 1995 Apr; 16(4 Suppl):263S-269S. PubMed ID: 7542899
[TBL] [Abstract][Full Text] [Related]
17. Characterization of choroid plexus in the preterm rabbit pup following subcutaneous administration of recombinant human IGF-1/IGFBP-3.
Ortenlöf N; Vallius S; Karlsson H; Ekström C; Kristiansson A; Holmqvist B; Göransson O; Vaváková M; Rydén M; Carey G; Barton N; Ley D; Gram M
Fluids Barriers CNS; 2023 Aug; 20(1):59. PubMed ID: 37582792
[TBL] [Abstract][Full Text] [Related]
18. Pilot dose-ranging of rhIGF-1/rhIGFBP-3 in a preterm lamb model of evolving bronchopulmonary dysplasia.
Albertine KH; Dahl MJ; Rebentisch A; Dawson E; Nabi A; Bowen S; Miers C; Wang Z; Yang H; Yu B; Null DM; Keefe D; Chung JK; Zhou Z; Barton N; Carey G; Ward R
Pediatr Res; 2023 May; 93(6):1528-1538. PubMed ID: 36030318
[TBL] [Abstract][Full Text] [Related]
19. Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model.
Wang W; Iresjö BM; Karlsson L; Svanberg E
Clin Nutr; 2000 Apr; 19(2):127-32. PubMed ID: 10867731
[TBL] [Abstract][Full Text] [Related]
20. Mixture of sugar and povidone-iodine stimulates healing of MRSA-infected skin ulcers on db/db mice.
Shi CM; Nakao H; Yamazaki M; Tsuboi R; Ogawa H
Arch Dermatol Res; 2007 Nov; 299(9):449-56. PubMed ID: 17680256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
